Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Immunocore Holdings plc is a biotechnology company developing immunomodulating medicines using its proprietary ImmTAX platform. Its focus includes cancer, infectious diseases, and autoimmune conditions, with key products like KIMMTRAK for uveal melanoma. The company leverages engineered TCRs to create off-the-shelf bispecific therapeutics targeting intracellular and cell surface proteins, aiming to improve patient outcomes through innovative, targeted immunotherapies.
This description was generated via AI from an annual report. Updated about 1 year ago.